Keyword Connections

neurodegeneration

Journals

41

1 Nutrients

2 Scientific reports

3 phytotherapy research : ptr

4 PloS one

5 The Journal of clinical investigation

6 acta neuropathologica communications

7 Journal of clinical nursing

8 Cell

9 PLoS computational biology

10 Aging cell

11 Communications chemistry

12 Cells

13 the european journal of neuroscience

14 Biochemical and biophysical research communications

15 physiologia plantarum

16 journal of biological inorganic chemistry : jbic : a publication of the society of biological inorganic chemistry

17 Cell reports

18 Biomolecules

19 neurobiology of aging

20 acta neuropathologica

21 scandinavian journal of work, environment & health

22 The Journal of neuroscience : the official journal of the Society for Neuroscience

23 journal of cellular physiology

24 the lancet child & adolescent health

25 brain, behavior, and immunity

26 integrative and comparative biology

27 Alzheimer's research & therapy

28 Journal of Neurochemistry

29 frontiers in neurology

30 ageing research reviews

31 experimental neurology

32 traffic

33 Metabolites

34 Molecular and cellular biochemistry

35 Journal of neuroinflammation

36 annual review of pharmacology and toxicology

37 Journal of pineal research

38 neuroimaging clinics of north america

39 pharmacology & therapeutics

40 Angewandte Chemie (International ed. in English)

41 Mymensingh medical journal : MMJ

Research Groups

0

No Research Group Connected

Bibliographies

121

1 Plasma cortisol is associated with cerebral hypometabolism across the Alzheimer's disease spectrum.

2 Big Data and Artificial Intelligence Modeling for Drug Discovery.

3 EMULSION: Transparent and flexible multiscale stochastic models in human, animal and plant epidemiology.

4 Metal coordination and peripheral substitution modulate the activity of cyclic tetrapyrroles on αS aggregation: a structural and cell-based study.

5 Tau oligomers mediate aggregation of RNA-binding proteins Musashi1 and Musashi2 inducing Lamin alteration.

6 Contemporary views on dementia as witchcraft in sub-Saharan Africa: a systematic literature review.

7 Age-related neurodegenerative diseases.

8 Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies.

9 Virgin Olive Oil and Health: Summary of the III International Conference on Virgin Olive Oil and Health Consensus Report, JAEN (Spain) 2018.

10 Individual Cryptic Scaling Relationships and the Evolution of Animal Form.

11 Nitric oxide-mediated regulation of oxidative stress in plants under metal stress: a review on molecular and biochemical aspects.

12 Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease.

13 Biomolecular Condensates in Neurodegeneration and Cancer.

14 Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology.

15 Zn entry through the mitochondrial calcium uniporter is a critical contributor to mitochondrial dysfunction and neurodegeneration.

16 Optimising medication data collection in a large-scale clinical trial.

17 Mercury and Alzheimer's Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization.

18 The influence of metallothionein treatment and treadmill running exercise on disease onset and survival in SOD1 amyotrophic lateral sclerosis mice.

19 The Role of Ca Signaling in Aging and Neurodegeneration: Insights from Models.

20 PrP (122-139) is a covert mitochondrial targeting signal of prion protein and it specifically triggers the perinuclear clustering of mitochondria in neuronal culture cells.

21 Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.

22 Underglycosylated prion protein modulates plaque formation in the brain.

23 Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity.

24 Postnatal zinc or paraquat administration increases paraquat or zinc-induced loss of dopaminergic neurons: insight into augmented neurodegeneration.

25 Novel Ocellatin Peptides Mitigate LPS-induced ROS Formation and NF-kB Activation in Microglia and Hippocampal Neurons.

26 Similarity of therapeutic networks induced by a multi-component herbal remedy, Ukgansan, in neurovascular unit cells.

27 The VGF-derived peptide TLQP21 impairs purinergic control of chemotaxis and phagocytosis in mouse microglia.

28 Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer's disease mice.

29 Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer's Disease.

30 The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

31 Horizontal transmission of severe acute respiratory syndrome coronavirus 2 to a premature infant: multiple organ injury and association with markers of inflammation.

32 Biomedical Research Goes Viral: Dangers and Opportunities.

33 Detergent-insoluble Inclusion Constitutes the First Pathology in PFN1 Transgenic Rats.

34 Diverse Applications of Artificial Intelligence in Neuroradiology.

35 primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration

36 progressive compromise of nouns and action verbs in posterior cortical atrophy

37 cellular and molecular basis of neurodegeneration in parkinson disease

38 the enzymatic core of the parkinson’s disease-associated protein lrrk2 impairs mitochondrial biogenesis in aging yeast

39 5-year imaging sequelae of concussive blast injury and relation to early clinical outcome

40 molecular diagnostics of neurodegenerative disorders

41 neuroinflammation and j2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration

42 astrocytes in oligodendrocyte lineage development and white matter pathology

43 aquaporin-4 reduces neuropathology in a mouse model of alzheimer’s disease by remodeling peri-plaque astrocyte structure

44 biometals in rare neurodegenerative disorders of childhood

45 protein phosphorylation in neurodegeneration: friend or foe?

46 neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit

47 connexins in the central nervous system: physiological traits and neuroprotective targets

48 perils of paediatric anaesthesia and novel molecular approaches: an evidence-based review

49 vitamin a and the nervous system

50 Medicinal plants for diabetes associated neurodegenerative diseases: A systematic review of preclinical studies.

51 the role of t1-weighted derived measures of neurodegeneration for assessing disability progression in multiple sclerosis

52 neuroimmunology of the interleukins 13 and 4

53 the cellular prion protein: a player in immunological quiescence

54 mitochondrial dynamics decrease prior to axon degeneration induced by vincristine and are partially rescued by overexpressed cytnmnat1.

55 novel eye movement disorders in whipple’s disease—staircase horizontal saccades, gaze-evoked nystagmus, and esotropia

56 a novel mouse model of penetrating brain injury

57 additional mechanisms conferring genetic susceptibility to alzheimer's disease

58 neural consequences of chronic short sleep: reversible or lasting?

59 co-expression patterns between atn1 and atxn2 coincide with brain regions affected in huntington’s disease

60 myeloid extracellular vesicles: messengers from the demented brain

61 vitamin d, homocysteine, and folate in subcortical vascular dementia and alzheimer dementia

62 control of intracellular calcium signaling as a neuroprotective strategy

63 mesenchymal stem cells: new players in retinopathy therapy

64 inducing chronic excitotoxicity in the mouse spinal cord to investigate lower motor neuron degeneration

65 threading granules in freiburg: 2nd international symposium on “one mitochondrion, many diseases – biological and molecular perspectives”, a frias junior researcher conference, freiburg im breisgau, germany, march 9th/10th, 2016

66 selective sparing of striatal interneurons after poly (adp-ribose) polymerase 1 inhibition in the r6/2 mouse model of huntington’s disease

67 compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?

68 energetics of excitatory and inhibitory neurotransmission in aluminum chloride model of alzheimer’s disease: reversal of behavioral and metabolic deficits by rasa sindoor

69 the ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution

70 the influences of age on olfaction: a review

71 neuronal cholesterol accumulation induced by cyp46a1 down-regulation in mouse hippocampus disrupts brain lipid homeostasis

72 commentary: gene therapy: a promising approach for neuroprotection in parkinson's disease?

73 mitochondrial dysfunction and neurodegeneration in multiple sclerosis

74 comment on successful therapies for alzheimer’s disease: why so many in animal models and none in humans?

75 Treatment of isolated REM-sleep behavior disorder using melatonin as a chronobiotic.

76 Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis.

77 Amperometry and Electron Microscopy show Stress Granules Induce Homotypic Fusion of Catecholamine Vesicles.

78 Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential.

79 Quantification and description of photothermal heating effects in plasmon-assisted electrochemistry.

80 Dysfunction of Thyroid Hormones Following Acute Coronary Syndrome in a Tertiary Care Hospital in Dhaka City.

81 Oxidative stress, cell cycle, and neurodegeneration

82 The roles of Flavonoles/Flavonoids in Neurodegeneration and Neuroinflammation.

83 Three-dimensional modeling of human neurodegeneration: brain organoids coming of age.

84 Chronic neurodegeneration by aflatoxin B1 depends on alterations of brain enzyme activity and immunoexpression of astrocyte in male rats

85 An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration

86 Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington's Disease.

87 Iron Pathophysiology in Neurodegeneration with Brain Iron Accumulation.

88 Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition

89 Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection.

90 VAC14 syndrome in two siblings with retinitis pigmentosa and neurodegeneration with brain iron accumulation.

91 Potential biomarkers for neuroinflammation and neurodegeneration at short and long term after neonatal hypoxic-ischemic insult in rat.

92 Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain.

93 Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease

94 Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?

95 Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.

96 Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity.

97 Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade

98 β-Amyloid(1–40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield

99 Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration

100 Peroxiredoxin-2 Protects against 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration via Attenuation of the Apoptosis Signal-Regulating Kinase (ASK1) Signaling Cascade

101 Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography